SGLT2 inhibitors: further evidence for heart failure with preserved ejection fraction as a metabolic disease?
Justin B. Echouffo-Tcheugui, Sabra C. Lewsey, Robert G. Weiss
Topics & Concepts
Heart failure with preserved ejection fractionInternal medicineCardiologyMedicineHeart failureDiabetes mellitusEjection fractionBlood pressureKidneyStroke volumeDiabetes Treatment and ManagementPancreatic function and diabetesCardiovascular Function and Risk Factors